Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin - PubMed (original) (raw)

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

P C Brooks et al. J Clin Invest. 1995 Oct.

Abstract

Angiogenesis plays a fundamental role in human breast tumor progression. In fact, recent findings indicate that vascular density is a prognostic indicator of breast cancer disease status. Evidence is presented that the integrin alpha v beta 3 is not only a marker of human breast tumor-associated blood vessels, but that it plays a significant role in human angiogenesis and breast tumor growth. To assess the role of alpha v beta 3-dependent angiogenesis in the progression of human breast cancer, we examined a SCID mouse/human chimeric model with transplanted full thickness human skin containing alpha v beta 3-negative human breast tumor cells. This tumor induced a human angiogenic response as measured by vascular cell immunoreactivity with monoclonal antibodies LM609 and P2B1 directed to human alpha v beta 3 and CD31, respectively. Intravenous administration of LM609 either prevented tumor growth or markedly reduced tumor cell proliferation within the microenvironment of the human skin. These LM609-treated tumors not only contained significantly fewer human blood vessels but also appeared considerably less invasive than tumors in control animals. These findings demonstrate that alpha v beta 3 antagonists may provide an effective antiangiogenic approach for the treatment of human breast cancer.

PubMed Disclaimer

Comment in

References

    1. Science. 1994 Apr 22;264(5158):569-71 - PubMed
    1. Biochim Biophys Acta. 1990 Jun 1;1032(1):89-118 - PubMed
    1. Semin Cancer Biol. 1992 Apr;3(2):49-56 - PubMed
    1. Lancet. 1992 Nov 7;340(8828):1120-4 - PubMed
    1. Am J Pathol. 1993 Aug;143(2):528-37 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources